The Efficacy of Rituximab in the Treatment of Membranous Nephropathy
Rituximab is a chimeric monoclonal antibody directed against the CD20 expressed on B cells, originally used to treat lymphoma but is increasingly used for the treatment of autoimmune diseases. Membranous nephropathy is an autoimmune disease resulting from the deposition of IgG and complements compo...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nepal Health Research Council
2021-01-01
|
| Collection: | Journal of Nepal Health Research Council |
| Accès en ligne: | https://jnhrc.com.np/index.php/jnhrc/article/view/2481 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|